Get started
Author

A. Vidal

Observed names: A Vidal, Adriana Vidal
ORCID: 0009-0009-6478-2228
Observed ORCID: 0009-0009-6478-2228
OpenAlex ID: A5111653644
Cardiac Findings in COVID-19 Patients Treated with HAZDPac
2025 · Sabine Hazan, Adriana Vidal, et al. · International Journal of Innovative Research in Medical Science
Independent multicenter validation of the prognostic significance of histopathologic tumor regression grade after neoadjuvant chemotherapy in bladder cancer
2019 · C.S. Voskuilen, H.Z. Oo, et al. · European Urology Supplements
429 Tumor Resistance to Anti-angiogenic Therapies in Renal Cell Carcinoma Tumorgraft Mouse Models
2012 · G. Jimenez, M. Martínez, et al. · European Journal of Cancer
384 Mechanisms of Tumor Malignization After Anti-angiogenic Therapies in Renal Cell Carcinoma
2012 · L. Moserle, M. Martinez, et al. · European Journal of Cancer
PDF
404 Multiple ErbBs Inhibition by Lapatinib Blocks Tumor Growth in Orthotopic Model of Human Testicular Germ Cell Tumour
2012 · M. Juliachs Mila, W. Castillo-Ávila, et al. · European Journal of Cancer
PDF
[Porcine proliferative enteropathy: prophylaxis and control]
2002 · Julián Solís García del Pozo, Ma Luisa de Arriba, et al.
[Porcine proliferative enteropathy: epidemiology and situation in Spain]
2001 · Julián Solís García del Pozo, Ma Luisa de Arriba, et al.
[Duodenal ulcerative disease without ulcer].
1982 · P Carayon, J P Deschamps, et al. · PubMed
Works count: 9
Citation count:
H-index:
I10-index:
Year
Topic
Type